References
- Ihara, M., Yamamoto, Y., Hattori, Y., Liu, W., Kobayashi, H.,
Ishiyama, H., Yoshimoto, T., Miyawaki, S., Clausen, T., Bang, O. Y.,
Steinberg, G. K., Tournier-Lasserve, E., & Koizumi, A. (2022).
Moyamoya disease: diagnosis and interventions. The Lancet Neurology,
21(8), 747–758. https://doi.org/10.1016/s1474-4422(22)00165-x
- Benkhaira, N., Kerouaz, N., & Kitouni, Y. (2022). Syndrome de
Moya-Moya chez une adulte révélé par une thrombose veineuse
cérébrale : à propos d’un cas. La Revue De Médecine Interne, 43,
A219–A220. https://doi.org/10.1016/j.revmed.2022.03.168
- Wang, X., Zou, Z., Bao, X., Wang, Q., Ren, B., Yu, D., Zhang, Q., Liu,
J., Hao, F., Gao, G., Guo, Q., Fu, H., Li, J., Wang, M., Liu, S., &
Duan, L. (2024). Clinical and genetic factors associated with
contralateral progression in unilateral moyamoya disease: Longitudinal
and Cross-Sectional Study. Heliyon, e26108.
https://doi.org/10.1016/j.heliyon.2024.e26108
- Li, J., Wang, X., Wang, Q., Bao, X., Guo, Q., Kong, Z., Gao, G., Wang,
M., Liu, S., Fu, H., Zhang, Q., & Duan, L. (2023). Long-term outcomes
after conservative and EDAS treatment for 111 elderly patients with
moyamoya disease: longitudinal and cross-sectional study. Journal of
Neurosurgery, 140(3), 800–808.
https://doi.org/10.3171/2023.7.jns231060
- Pashkov, A., Filimonova, E., Martirosyan, A., Ovsyannikov, K.,
Gunenko, G., Moysak, G., & Rzaev, J. (2023). Profile of speech and
cognitive impairments in a patient with moyamoya disease: a
longitudinal case study. medRxiv (Cold Spring Harbor Laboratory).
https://doi.org/10.1101/2023.08.29.23294546
- Araki, Y., Takagi, Y., Ueda, K., Ubukata, S., Ishida, J., Funaki, T.,
Kikuchi, T., Takahashi, J. C., Murai, T., & Miyamoto, S. (2014).
Cognitive Function of Patients with Adult Moyamoya Disease. Journal of
Stroke and Cerebrovascular Diseases, 23(7), 1789–1794.
https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.04.032
- Nielsen, T. H., Abhinav, K., Sussman, E. S., Han, S. S., Weng, Y.,
Bell-Stephens, T., Cnrn, N., Heit, J. J., & Steinberg, G. K. (2020).
Direct versus indirect bypass procedure for the treatment of ischemic
moyamoya disease: results of an individualized selection strategy.
Journal of Neurosurgery, 134(5), 1578–1589.
https://doi.org/10.3171/2020.3.jns192847
- Kim, E., Lee, H., Chung, J., Ji, S., Jang, Y., Lee, J., Kim, J., &
Kim, H. (2020). Flow-Mediated Dilatation of the Brachial Artery for
Assessing Endothelial Dysfunction in Children with Moyamoya Disease.Pediatric Neurosurgery , 55 (3), 149–154.
https://doi.org/10.1159/000509406
- Toh, K. Z., Koh, M. Y., Loh, E. D., Sia, C., Chong, Y., Yeo, L. L.,
Sharma, V. K., Lim, M. J., & Tan, B. Y. (2023). Prevalence and
Associations of Cognitive Impairment in Adult Patients with Moyamoya
Disease: A Systematic Review and Meta-Analysis. Journal of Alzheimer S
Disease, 97(2), 541–552. https://doi.org/10.3233/jad-230979
- Sperber, C., & Karnath, H. (2015). Topography of acute stroke in a
sample of 439 right brain damaged patients. NeuroImage
Clinical , 10 , 124–128.
https://doi.org/10.1016/j.nicl.2015.11.012
- Memetoglu, O. G., Taraktas, A., Badur, N. B., & Ozkan, F. U. (2014).
Impact of stroke etiology on clinical symptoms and functional status.Northern Clinics of Istanbul , 1 (2).
https://doi.org/10.14744/nci.2014.40327
- Ahtam, B., Solti, M., Doo, J. M., Feldman, H. A., Vyas, R., Zhang, F.,
O’Donnell, L. J., Rathi, Y., Smith, E. R., Orbach, D., See, A. P.,
Grant, P. E., & Lehman, L. L. (2023). Diffusion-Weighted Magnetic
Resonance Imaging Demonstrates White Matter Alterations in Watershed
Regions in Children With Moyamoya Without Stroke or Silent Infarct.Pediatric Neurology , 143 , 89–94.
https://doi.org/10.1016/j.pediatrneurol.2023.03.005
- Liu, Z., He, S., Xu, Z., Duan, R., Yuan, L., Xiao, C., Yi, Z., &
Wang, R. (2020). Association between white matter impairment and
cognitive dysfunction in patients with ischemic Moyamoya disease.BMC Neurology , 20 (1).
https://doi.org/10.1186/s12883-020-01876-0
- Yamada, Y., Matsui, K., Takeuchi, I., & Fujimaki, T. (2015).
Association of genetic variants with coronary artery disease and
ischemic stroke in a longitudinal population-based genetic
epidemiological study. Biomedical Reports , 3 (3),
413–419. https://doi.org/10.3892/br.2015.440
- Sun, W., Ruan, Z., Dai, X., Li, S., Li, S., Zhang, J., Chen, J.,
Zhang, H., & Xu, H. (2018). Quantifying Hemodynamic Changes in
Moyamoya Disease Based on Two-Dimensional Cine Phase-Contrast Magnetic
Resonance Imaging and Computational Fluid Dynamics. World
Neurosurgery , 120 , e1301–e1309.
https://doi.org/10.1016/j.wneu.2018.09.057
- Su, H., & Yu, J. (2024). Effect of moyamoya disease on the basilar
artery and adjacent arteries on CTA. eNeurologicalSci , 100501.
https://doi.org/10.1016/j.ensci.2024.100501
- Yamamoto, S., Funaki, T., Fujimura, M., Takahashi, J. C., Uchino, H.,
Houkin, K., Tominaga, T., Miyamoto, S., & Kuroda, S. (2019).
Development of Hemorrhage-prone Anastomoses in Asymptomatic Moyamoya
Disease—A Comparative Study with Japan Adult Moyamoya Trial.Journal of Stroke and Cerebrovascular Diseases , 28 (11),
104328. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.104328
- Jang, D., Lee, K., Rha, H. K., Huh, P., Yang, J., Park, I. S., Ahn,
J., Sung, J. H., & Han, Y. (2016). Bypass surgery versus medical
treatment for symptomatic moyamoya disease in adults. Journal of
Neurosurgery , 127 (3), 492–502.
https://doi.org/10.3171/2016.8.jns152875
- Yamamoto, Y., Nagakane, Y., Makino, M., Ohara, T., Koizumi, T.,
Makita, N., & Akiguchi, I. (2014). Aggressive Antiplatelet Treatment
for Acute Branch Atheromatous Disease Type Infarcts: A 12-year
Prospective Study. International Journal of Stroke ,9 (3), E8. https://doi.org/10.1111/ijs.12200